SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-KSB
                Annual Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                   For the fiscal year ended December 31, 1998
                          Commission File number 1-7301

                           Renu-U International, Inc.
                           --------------------------
             (Exact name of Registrant as Specified in its Charter)

               Delaware                                        75-1329265
     ------------------------------                       --------------------
    (State or other jurisdiction of                         I.R.S.  Employer
    incorporation  or  organization)                      Identification  Number

          14251  Chambers  Rd,  Tustin  Ca                            92780
        ----------------------------------------------------------------------
          (Address  of  principal  executive  offices)            (Zip  Code)

Issuer's  telephone  number,  including  area  code:  (714)  666-2020

Securities registered pursuant to Section 12(b) of the Act:  NONE

Securities registered pursuant to Section 12(g) of the Act:  COMMON STOCK,
$.001  PAR  VALUE

     Check whether the registrant (1) has filed all reports required to be filed
by  Section  13  or  15(d)  of  the  Securities  Exchange Act of 1934 during the
preceding  12  months (or for shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past  90  days.               Yes  X    No
                                  ---      ---

     Check  if  there  is no disclosure of delinquent filers in response to Item
405  of  Regulation  S-B  contained  in  this  form,  and  no disclosure will be
contained,  to  the  best  of  registrant's  knowledge,  in  definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or  any  amendment  to  this  Form  10-KSB.  [__]

     The  issuer's  revenues  for  the  fiscal year ended December 31, 1998 were
$89,638.

     The  aggregate  market  value  of  voting  stock  held  by  non-affiliates
(9,996,124  shares) of the registrant, based upon the closing sales price of the
registrant's  common  stock  as reported on the NASD Bulletin Board on August 3,
1999,  was  approximately  $1,681,450

     Indicate  the  number  of  shares  outstanding  of each of the registrant's
classes  of  common stock, as of August 3, 1999: 99,961,241 before reverse stock
split.(see  Item  6  -  subseq  events)

<PAGE>
                                TABLE OF CONTENTS
PART  I
-------

Item  1.  Business                                                             3

Item  2.  Properties                                                           4

Item  3.  Legal  Proceedings                                                   4

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders          4

PART  II
--------

Item  5.  Market for Company's Common Equity and Related Stockholder Matters   4

Item  6.  Plan  of  Operations                                                 5

Item  7.  Financial  Statements                                                7

Item  8.  Changes  in  and  Disagreements  with  Accountants  on
          Accounting  and  Financial  Disclosure                               7

PART  III
---------

Item  9.  Directors, Executive Officers, Promoters and Control Person;
          Compliance  with  Section  16(a)  of  the  Exchange  Act             8

Item  10. Executive  Compensation                                              9

Item  11. Security Ownership of Certain Beneficial Owners and Management       9

Item  12. Certain  Relationships  and  Related  Transactions                  10

Item  13. Exhibits  and  Reports  on  Form  8-K                               10

FINANCIAL STATEMENTS                                                          11
---------------------

                                        2
<PAGE>
ITEM  1.  DESCRIPTION  OF  BUSINESS1ITEM  1.  DESCRIPTION  OF  BUSINESS
-----------------------------------------------------------------------

     The  following  narrative  of  this  annual  report  contains some "forward
looking statements"  which are based upon the plans, goals and objectives of the
Company  and  its  management.  Such statements are subject to various risks and
uncertainties.  Numerous  factors  exist  within  the  business  world which may
prevent  the  successful  attainment  of  such  plans,  goals  and  objectives.
Consequently,  the  reader  should  carefully consider the fact that such risks,
uncertainties,  and  unknown factors may cause actual results to vary materially
from  the  future  results  sought  and/or  discussed  by  the  Company  in such
forward-looking  statements.


     BUSINESS  PLAN

     The  Company  has  completed  a line of its own Bio-Resonance Therapy (BRT)
Devices  which  are  used  in  treatment of a variety of physical ailments.  The
Company  sells  its  hand-held  BRT units and leases its larger, or professional
units,  to  hospitals,  doctors,  chiropractors  and  physical  therapistsThe
business  plan  for  this  venture has not been fully developed at this time.


     CORPORATE  HISTORY

     The  Registrant  has  experienced  several  changes in management, control,
capital structure and corporate name since its inception in 1971.  The following
chronology  is  derived  from  corporate  records  in  the possession of current
management  and  from historical financial statements and periodic reports filed
with  the  Commission.  Such  chronology  is  accurate  to the best knowledge of
current  management  who  has  been associated with the Registrant since 1986.

     Renu-U  International,  Inc.  (the  "Registrant"  or  "the  Company")  was
incorporated  under the laws of the State of Delaware on June 14, 1971 under the
name  of  Worldcom, Inc. The Worldcom shares were traded in the over-the-counter
securities  market.

     The  registrant  filed a Form 10 registration statement with the Securities
and  Exchange Commission in May of 1972.  Registrant discontinued its operations
after  1976  and  was  inactive  from  approximately  1976  until  June  1988.

     In  1996,  the  Company  started  work  with  Dr. Jean-Francois Hibbert, of
Harris,  New  York.  Subsequently, the Company worked with Dr. Michael Wall, who
continues  with  the  Company  on its advisory board.  This work resulted in the
Company  developing a new business opportunity in the field of physical care and
development.  The  Company  is  currently  selling a line of hand-held BRT units
and  leasing  commercial  BRT  units.  See  Item  6  (  Plan  of  Operations and
Subsequent  Events).

                                        3
<PAGE>
ITEM  2.  DESCRIPTION  OF  PROPERTY2.  DESCRIPTION  OF  PROPERTY
----------------------------------------------------------------

     The  Registrant  currently  owns  no  properties.  The  Company  currently
occupies  approximately  1,000 square feet of office space for a monthly rent of
$500.  The  Company  had  maintained its first wellness center in Tarrytown, New
York  but  has  since  moved  the  center  to  Salt  Lake  City,  Utah.

ITEM  3.  LEGAL  PROCEEDINGS3.  LEGAL  PROCEEDINGS
--------------------------------------------------

     There  are  currently  no  legal  proceedings pending or threatened against
Registrant  to  the  knowledge  of  its  officers.

ITEM  4.  SUBMISSION  OF  MATTERS TO A VOTE OF SECURITY HOLDERS4.  SUBMISSION OF
--------------------------------------------------------------------------------
MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS
-------------------------------------------

     There  were  no  matters  submitted  to  the shareholders during the fourth
quarter  of  1998.


                                     PART II

ITEM  5.  MARKET  FOR  COMPANY'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS5.
--------------------------------------------------------------------------------
MARKET  FOR  COMPANY'S  COMMON  EQUITY  AND  RELATED  STOCKHOLDER  MATTERS
--------------------------------------------------------------------------

     The  trading  symbol  for the Company's common stock RNUI, and is currently
quoted  at  a  $.52  offer.  Though  the  Company  has  been  unable  to  obtain
historical  quotation  information  for  the Company's stock, it is management's
belief  that  the  stock  has  been quoted at between $.09 and $.52 for the last
year. There has only been a limited public trading market for such stock for the
preceding  several years.  As of the  date of this report, there were 99,961,241
shares of Common Stock outstanding, before the reverse stock split in July 1999,
held  by  3,759  holders  of  record,  including  broker-dealers  and  clearing
corporations  holding  shares  on  behalf of their customers.  No dividends have
been  declared by the Registrant during the seven most recent fiscal years.  The
Registrant  has  no  plans  to  pay  cash  dividends  in  the  near  future.

ITEM  6.  PLAN  OF  OPERATIONS  (MD&A)6.  PLAN  OF  OPERATIONS  (MD&A)
----------------------------------------------------------------------

OVERVIEW

     In early 1996, the Company started work with Dr. Jean-Francois Hibbert, MD,
and  later  Dr.  Michael  Wall,  MD.  This  work  has  resulted  in  the Company
developing  a  new  business  opportunity  in  the  field of pain management and
physical  wellness  utilizing  the  Company's  Bio-Resonance  Therapy  ("BRT").
Consequently,  the  Company  is  working  towards  owning  and  operating  pain
management  and  physical  wellness  centers  (hereafter  "the  Centers"),lease
commercial  BRT  units,  and  sell  hand-held  BRT  units  domestically  and
internationally.

                                        4
<PAGE>
     An  initial  Center  was  located in New York in 1997, but was moved in May
1998  due to logistical difficulties in operating the center at a great distance
from  the  Company's  headquarters  in  Salt  Lake  City,  Utah.  Management  is
currently  operating  a  center  in  Salt  Lake  City,  Utah.

     BRT  theories  were  first  developed in the far east in the 1970s and were
based  on  the  theory  of human energy fields.  The Company and its consultants
have  designed  and  improved  the  BRT  devices (hereafter "Device") to be more
efficient  and  effective.  The Device operates on  both 110 volts and 220 volts
to  generate  an  evenly  heated pattern of energy field.  The designers believe
this  field duplicates the natural energy field generated by the human body and,
therefore,  assists  the human body to minimize or reduce pain and self heal.  A
BRT  would be categorized under FDA guidelines as a non-invasive medical device.
Some  of the components for these Devices will be imported and then assembled in
the  United  States exclusively for the Company.  Management does not anticipate
any  difficulty  in  obtaining  the  necessary  devices.

     The  Company  has worked with a foreign manufacturer for the past two years
to develop a hand-held BRT unit and have now commenced production and marketing.
This smaller unit will operate under the same principals as the device installed
in the Centers, but at significantly lower capacity.  These smaller devices will
be  marketed  through  a  variety of marketing channels for home use.  In may of
1998 the Company entered into an exclusive product license agreement with Sureal
International,  Inc.  Pursuant  to the Agreement, Sureal has the exclusive right
for  merchandising,  marketing, distribution, promotion and selling of hand held
BRT units under the trade name Sureal BRT or Sureal Bio-Resonance Therapy for as
long  as the minimum unit purchases are met.  The exclusivity excludes Thailand,
Singapore, Malaysia, Indonesia, Hong Kong, China and Taiwan as territories.  The
minimum  purchases  are  3,000  units  within six months of the agreement, 2,000
units  for  the  three month period after November 1, 1998, and then 3,000 units
per  month  thereafter.  Sureal  has  paid  the  Company  an  advance payment of
$5,000 towards the licensing fee of $250,000.  The licensing fee is due upon the
earlier  of  nine months from the date of the agreement, or upon completion of a
public  offering  by  Sureal.

FINANCIAL  CONDITION

The  Registrant  is  currently  conducting only limited business operations.  At
December  31,  1998,  the  Registrant  had current assets of $35,040 and current
liabilities  of  $  334,788.
The  Company  has  sustained  substantial  losses  and does not have the current
assets  to service its current liabilities for the coming year, however   during
June  1999  all  assets  were transferred in exchanged for the assumption of all
liabilities.  (  See  Subsequent  Events)

     The Company expended  $25,000 towards the purchase of the proprietary molds
used  in  the  production  of  the  new  BRT hand held devices.  The Company has
currently  expended  over  $40,000  towards  the  manufacture  and  delivery  of
inventory  in  1998.

     The Registrant will need additional  funding  beyond  managements'  current
expectations in order to pay its obligations, file periodic reports and continue
its  currently planned business of owning and operating pain management centers,
the  Registrant  will need to enter into an agreement for the provisions of such
additional  funding  and  no  assurances  can be given that such funding will be
available  to  the  Registrant  on  terms  acceptable  to  it  or  at  all.

                                        5
<PAGE>
     As  a  small  business,  shareholders  of  the  Company must bare the risks
associated  with  ownership in a company in its early stages of development with
limited  or  no  resources, undeveloped product markets and limited staffing and
facilities.  Additionally,  due  to  current  market  factors  of  "low  price"
securities,  often  referred  to  as "penny stocks", shareholders of the Company
must  bare  the risk of owning securities with limited liquidity or no liquidity
at  all.

SUBSEQUENT  EVENTS

During  June  1999  the  Company  transferred all assets and its business in the
physical  care  field  in  exchange for the assumption of all its liabilities as
part of an acquisition and reorganization between the Company and RGB Technology
Group,  Inc.  and  Kimrose  Holdings  which  included the issuance of 90,000,000
shares of the Company and then  a reverse stock split of the Company stock at 30
shares  of  outstanding  stock  for  one  share.

See  form  8-K  filed  in  July  2,  1999  for  a  disclosure  of  the above and
notification  of  a  change  in  officers  and  a  change  in  accountants.

ITEM  7.  FINANCIAL  STATEMENTS
-------------------------------

     The Registrant's audited financial statements  for the years ended 1998 and
1997  are  included  herein.

ITEM  8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING AND
--------------------------------------------------------------------------------
FINANCIAL  DISCLOSURE8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON
-------------------------------------------------------------------------------
ACCOUNTING  AND  FINANCIAL  DISCLOSURE
--------------------------------------

     There  are  no  disagreements  between  the  Registrant  and  any  of  the
accountants  on  any  matter  of accounting principles or practices or financial
statement  disclosure.  In  1999  the  Company  appointed Andersen, Andersen and
Strong  as  its  independent auditors to replace the Company's previous auditing
firm  Crouch  Bierwolf and Chrisholm.  The appointment of Andersen, Andersen and
Strong  was  not  the  result  of  any  dispute  with  the  prior  firm.

                                    PART III

ITEM  9.  DIRECTORS,  EXECUTIVE  OFFICERS,  PROMOTERS  AND  CONTROL  PERSONS;
-----------------------------------------------------------------------------
COMPLIANCE  WITH  SECTION 16(A) OF THE EXCHANGE ACTITEM 9.  DIRECTORS, EXECUTIVE
--------------------------------------------------------------------------------
OFFICERS,  PROMOTERS  AND  CONTROL PERSONS; COMPLIANCE WITH SECTION 16(A) OF THE
--------------------------------------------------------------------------------
EXCHANGE  ACT
-------------

                                        6
<PAGE>
EXECUTIVE  OFFICERS  AND  DIRECTORS

     The  Executive  Officers  and  Directors of the Company at the date of this
filing  are  as  follows

                                                              Year  First
          Name           Age           Position             Elected/Appointed
          ----           ---           --------             -----------------

     Donald H. Hansen    73      President and Director           1999

     John  D.  Jantzi    52      Vice  President and Dir.         1999

     Julie  Kim          25      Vice  President,                 1999
                                 Secretary, Treasurer
                                 and  Director

                                        7
<PAGE>
     The  term of office of each director is one year and until his successor is
elected  at  the  Registrant's  annual  shareholders'  meeting and is qualified,
subject  to removal by the shareholders.  The term of office for each officer is
one  year  and until his successor is elected at the annual meeting of the Board
of  Directors  and  is  qualified, subject to removal of the Board of Directors.

     DONALD  H.  HANSEN,  O.D., President and Director, Dr. Hansen, age 73, is a
graduate of Coe College in Cedar Rapids, Iowa, and the Illinois College in Cedar
Rapids,  Iowa, and the Illinois College of Optometry.  He has owned and operated
the  Main  Vision  Clinic  & Contact lens Center of Davenport, Iowa, since 1968.
Since  1993,  Dr.  Hansen  has been the President/CEO of The American College of
Ophthermology, Inc., and Supervision Research Development Company, Inc., both of
which  are devoted to research into eye temperature measurement and diagnosis of
health  problems  based  on  ocular  thermal  mapping.  Dr. Hansen has conducted
extensive  research  on  the  relationship  between  low  ocular  blood flow and
increased  risk  of  stroke  and  heart  attack.  He  is  a  member  of numerous
professional  organizations,  including  American Optometric Association and the
Iowa  Optometric Association.  Dr. Hansen is the founder of the National Council
of  Ophthalmic  Inventors  and  the  National  Care  Association.

     JOHN  D. JANTZI, O.D., Vice President and Director.  Dr. Jantzi is 52 years
of  age.  He  received  his  Doctor  of  Optometry degree from the University of
Waterloo  in  1975,  and was granted a Master of Science degree in physiological
optics  in 1981.  Dr. Jantzi has practiced optometry in the Vancouver area since
that  time.  He  co-produced the award winning television program "Life is Worth
Seeing,"  which  is  televised  annually  by  the  Knowledge  Network in British
Columbia.  Dr.  Jantzi  is  a  frequent lecturer and has participated in over 30
clinical  research  projects  with  the  U.S.  Food  and Drug Administration and
numerous  major  ophthalmic  corporations.  He  was  the  editor-in-chief of the
Canadian  Vision  science  journal  Practical  Optometry from 1990 to 1998.  Dr.
Jantzi  is  a  member  of  the Canadian Association of Optometrists, the Ontario
Association  of  Optometrists,  and  the  British  Columbia  Association  of
Optometrists.

                                        8
<PAGE>
     JULIE  KIM, AGE 25, graduated from Cornell University in 1997 with a degree
in  Business  Administration.  From 1995 to 1996, she was the Vice President for
Development  of LightDrive Technologies, Inc., of Ft. Lauderdale, Florida.  From
1997  to  1998, she served as a Consultant for Ernst & Young LLP and E&Y Kenneth
Leventhal  Real Estate Group in New York City and Miami.  Ms. Kim is the creator
of  Lodging  Magazine's  Lodging  Stock  Index,  which tracks the performance of
lodging  stocks  versus  the  Standard & Poor's 500.  Ms. Kim is a member of the
Cornell  Society  of  Hotelmen.

COMPLIANCE  WITH  SECTION  16(A)  OF  THE  EXCHANGE  ACT

     Based  solely  upon  a  review  of  Forms  3 and 4, and amendments thereto,
furnished  to  the  Registrant under Rule 16a-3(d) during its most recent fiscal
year  and  Forms  5,  and  amendments  thereto, furnished to the Registrant with
respect  to  its  most  recent  fiscal  year, there have been no failure to file
reports  on  a  timely basis as required by Section 16(a) during the fiscal year
ended  December  31,  1996,  or  since that time, except for the failure to file
annual  reports  on  Form  5.  There  have,  however,  been  no changes in stock
ownership  of  such  persons  required  to  file  during  those  periods.

                                        9
<PAGE>
ITEM  10.  EXECUTIVE  COMPENSATIONITEM  10.  EXECUTIVE  COMPENSATION
--------------------------------------------------------------------

     During the fiscal year ended December 31, 1998, the Company's President and
CEO  received  no salary or other compensation for  his services.  The Company's
vice  president,  Mr. Lu, did receive approximately $20,850 compensation for the
year  plus  approximately $4,400 in advances toward travel expenses.  There have
been  no transactions between the Registrant and any individual named in Item 9,
except  as  set  forth  in  this  Item  10.

ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENTITEM 11.
--------------------------------------------------------------------------------
SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS  AND  MANAGEMENT
---------------------------------------------------------------------

     The  following is a list of security ownership of management and beneficial
owners  who  owned  or possessed voting control exceeding 5% of the Registrant's
outstanding Shares at August 3, 1999, after the completion of transactions shown
in  the  subsequent  events  Item 6 and before the reverse stock split, at which
time  the  Company  had  99,961,241  common  shares  outstanding.

Title                Name                       Amount               Percent
of Class           and Address                of Ownership           of Class
-----------------------------------          -------------          ---------

Common          Donald  H.  Hansen              500,000                .5

                John  D.  Jantzi                500,000                .5

                Julie  Kim                      450,000                .5

                Kimrose  Holding             90,000,000                90.

                All Officers and Directors
                and  benefical  owner
                as  a  group                 91,400,000              91.4

                                       10
<PAGE>
ITEM  12.  CERTAIN  RELATIONSHIPS  AND  RELATED  TRANSACTIONSITEM  12.  CERTAIN
-------------------------------------------------------------------------------
RELATIONSHIPS  AND  RELATED  TRANSACTIONS
-----------------------------------------

     None.

ITEM 13.  EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES, AND REPORTS ON FORM 8-KITEM
--------------------------------------------------------------------------------
13.  EXHIBITS,  FINANCIAL  STATEMENTS,  SCHEDULES,  AND  REPORTS  ON  FORM  8-K
-------------------------------------------------------------------------------

                                                                            Page
                                                                             No.
                                                                             ---

     1.     Documents  filed  with  this  report:

            The  following  financial  statements  are  included
            immediately  following  this  report.

            Certified  Public Accountant's Audit Report                      11
            Balance  Sheets                                                  13
            Statements  of  Operations                                       14
            Statements of Changes in Stockholders' Equity                    15
            Statements  of  Cash  Flows                                      18
            Notes  to  Financial  Statements                                 19

     2.     Reports  on  Form  8-K

            None

     3.     Exhibit  Index

     4.     Consent  of  Andersen.  Andersen  and  Strong  EX-23.1

     5.     Letter  from  Crouch,  Bierwolf  &  Chisholm  EX-23.2

     6.     Financial  Data  Schedule  EX-27


                                   SIGNATURES


     Pursuant  to  the  requirements of Section 15(d) of the Securities Exchange
Act  of 1934, the Company has duly caused this report to be signed on its behalf
by  the  undersigned,  hereunto  duly  authorized.


Date:  August   ,  1999

                                                    RENU-U INTERNATIONAL, INC.

                                                    /s/ Donald H.  Hansen
                                                    ---------------------------
                                                    Donald H. Hansen, President

                                       11
<PAGE>
     Pursuant  to  the requirements of the Securities Exchange Act of 1934, this
report  has  been  signed  below  by  the  following  persons  on  behalf of the
registrant  and  in  the  capacities  and  on  the  dates  indicated.

        Name                        Title                           Date
        ----                        -----                           ----

/s/Donald  H.  Hansen
---------------------      President and Director             August 20, 1999
Donald H. Hansen           (Principal Executive Officer)


/s/  Julie  Kim
---------------------      Secretary and Director             August 20, 1999
Julie  Kim                 (Principal Accounting Officer)

                                       12
<PAGE>
                          Independent Auditors' Report
                          ----------------------------


To  the  Board  of  Directors  and  Stockholders  of  Renu-U International, Inc.

We  have audited the accompanying balance sheet of Renu-U International, Inc. (a
development  stage company)  at  December 31, 1998 and the related statements of
operations,  stockholders' equity and cash flows for the year then ended.  These
financial  statements  are  the responsibility of the Company's management.  Our
responsibility  is  to express an opinion on these financial statements based on
our  audit.  The  financial  statements  of  Renu-U  International,  Inc.  as of
December  31,  1997  and  for  the  period  from  January  1, 1983 (beginning of
development  stage)  to  December 31, 1997, were audited by other auditors whose
report  dated  July  16,  1998,  expressed  an  unqualified  opinion  on  these
statements.

We  conducted  our  audits  in  accordance  with  generally  accepted  auditing
standards. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing  the  accounting  principles  used  and  significant estimates made by
management,  as well as evaluating the overall financial statement presentation.
We  believe  that  our  audits  provide  a  reasonable  basis  for  our opinion.

In  our  opinion,  the financial statements referred to above present fairly, in
all  material  respects, the financial position of Renu-U International, Inc. as
of  December  31,  1998 and the results of its operations and cash flows for the
year  then  ended.

The  accompanying  financial  statements  have  been  prepared assuming that the
Company  will  continue  as  a  going  concern.  The  Company  has  sustained
substantial  losses  and does not have the current assets to service its current
liabilities  for  the  coming  year  which  raises  substantial  doubt about its
ability  to  continue as a going concern.  Management's plans and the subsequent
events  in  regard  to  these  matters  are  described  in notes 4 and 6.  These
financial  statements  do not include any adjustments that might result from the
outcome  of  this  uncertainty.

Salt  Lake  City,  Utah
August  5,  1999

                                       13
<PAGE>
<TABLE>
<CAPTION>
                           RENU-U INTERNATIONAL, INC.
                          ( Development Stage Company)
                                  Balance Sheet
                                December 31, 1998

                                     ASSETS
                                     ------


<S>                                                                <C>
Current Assets
   Cash                                                            $        47
   Inventory - for resale                                               35,040
                                                                   ------------

         Total Current Assets                                           35,087
                                                                   ------------

Property and Equipment - net of accumulated depreciation - Note 2       29,645
                                                                   ------------

                                                                   $    64,732
                                                                   ============


                    LIABILITIES AND STOCKHOLDERS' EQUITY
                    -------------------------------------

Current Liabilities
    Notes payable                                                  $    89,922
    Notes payable - related parties                                     64,820
    Accounts payable - trade                                           152,279
    Accounts payable - related parties                                  27,767
                                                                   ------------

         Total current liabilities                                     334,788
                                                                   ------------

Long term debt - Note 3                                                 44,472
                                                                   ------------

Stockholders' Equity
    Preferred stock, $.10 par value 1,000,000 shares
       authorized, no shares issued or outstanding                           -

    Common stock $.001 par value, 100,000,000 shares
        authorized, 9,961,241 shares issued and outstanding              9,961

     Capital in excess of par value                                    753,342

     Accumulated deficit during development stage - Note 1          (1,077,831)
                                                                   ------------
          Total Stockholders' Deficiency                              (314,528)

                                                                   $    64,732
                                                                   ============
</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       14
<PAGE>
<TABLE>
<CAPTION>
                           RENU-U INTERNATIONAL, INC.
                          ( Development Stage Company)
                            Statements of Operations


                                                            For  the
                                                         Period  During
                                                         the Development
                                                            Stage from
                                                         January 1, 1983
                                          Year  ended
                                           Through
                                        December  31,
                                   ------------------------ December  31,
                                      1998         1997         1998
                                   -----------  -----------  ----------

<S>                                <C>          <C>          <C>
Revenues                           $   89,638   $   27,851   $ 117,489

Cost of Sales                          27,880       11,391      39,271
                                   -----------  -----------  ----------

     Gross Profit                      61,758       16,460      78,218

Selling, General &
     Administrative Expenses          145,513      176,413     604,998
                                   -----------  -----------  ----------


    Net Loss                       $  (83,755)  $ (159,953)  $(526,780)
                                   ===========  ===========  ==========


Net loss per common share

    Basic                          $     (.01)  $     (.02)
                                   -----------  -----------  ----------


Average common shares outstanding

     Basic                          9,961,241    9,961,241
                                   -----------  -----------  ----------
</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       15
<PAGE>
<TABLE>
<CAPTION>
                                      RENU-U INTERNATIONAL, INC.
                                     ( Development Stage Company)
                                  Statements of Stockholders' Equity

                                                              Common Stock        Capital    Retained
                                                          ---------------------  In Excess   Earnings
                                                            Shares      Amount    of Par    (Deficit)
                                                          -----------  --------  ---------  ----------
<S>                                                       <C>          <C>       <C>        <C>
Balance-January 1, 1983 - date of inception of             1,058,680   $ 1,059   $549,992   $(551,051)
        development stage
  Issuance of common stock to acquire 100% of
    Selinger Pharmaceuticals, Inc., June, 1983 at
    $.03 per share                                         4,234,720     4,235      8,265           -

  Net loss for the year ended December 31, 1983                    -         -          -     (12,500)
                                                          -----------  --------  ---------  ----------

Balance-December 31, 1983                                  5,293,400     5,294    558,257    (563,551)

  Net Income for the year ended December 31, 1984                  -         -          -           -
                                                          -----------  --------  ---------  ----------

Balance-December 31, 1984                                  5,293,400     5,294    558,257    (563,551)

  Issuance of common stock to acquire 100% of
    outstanding common stock of Selinger
    Development, Inc., October 1985                          500,000       500       (500)          -

Net Loss for the year ended December 31, 1985                      -         -          -     (19,365)
                                                          -----------  --------  ---------  ----------

Balance-December 31, 1985                                  5,793,400     5,794    557,757    (582,916)

  Rescission of acquisition of Selinger
    Development, Inc., May, 1986                                   -         -          -           -

  Cancellation of common stock in connection with
    recision of acquisition of Selinger Development Inc.    (500,000)     (500)       500           -

  Cancellation of common stock in connection
    with recision of acquisition of Selinger
    Pharmaceuticals, Inc.                                 (2,694,562)   (2,695)     2,695           -

  Issuance of common stock in private placement
    at $.25 per share, October 1986                          160,000       160     39,840           -

  Net Loss for the year ended December 31, 1986                    -         -          -     (38,552)
                                                          -----------  --------  ---------  ----------

Balance-December 31, 1986                                  2,758,838     2,759    600,792    (621,468)

  Issuance of common stock in private placement
    at $.25 per share, February-March, 1987                  120,000       120     29,880           -

  Cancellation of common stock in connection with
    recision of acquisition of Selinger
    Pharmaceuticals, Inc.                                   (594,347)     (594)       594           -

  Net loss for the year ended December 31, 1987                    -         -          -     (19,124)
                                                          -----------  --------  ---------  ----------

Balance-December 31, 1987                                  2,284,491     2,285    631,266    (640,592)

  Issuance of common stock for services rendered by
    Officers of the Corporation; May, 1988 at $.02
    per share                                                500,000       500      9,500           -

</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       16
<PAGE>
<TABLE>
<CAPTION>
                                    RENU-U INTERNATIONAL, INC.
                                   ( Development Stage Company)
                          Statements of Stockholders' Equity (Continued)

                                                            Common  Stock     Capital    Retained
                                                        -------------------  In Excess   Earnings
                                                          Shares    Amount    of Par    (Deficit)
                                                        ----------  -------  ---------  ----------
<S>                                                     <C>         <C>      <C>        <C>
  Issuance of common stock in private placement at
    $.25 per share                                      $  360,000  $   360  $ 89,640   $       -

  Cancellation of $90,000 note to Uromedic                       -        -   (90,000)          -

  Net Loss for the year ending December 31, 1988                 -        -         -     (30,002)
                                                        ----------  -------  ---------  ----------

Balance-December 31, 1988                                3,144,491    3,145   640,406    (670,594)

  Contribution from officer, January 1, 1989                     -        -    17,072           -

  Issuance of common stock to officer for payment
    of corporate liability January 1, 1989 at $.003
    per share                                            5,776,750    5,776     9,763           -

  Issuance of common stock for cash at $.01 per
    share to officers of the Corporation, May 1989         500,000      500     4,500           -

  Issuance of common stock for cash at $.02 per share
    to officers of the Corporation, September 1989         500,000      500     9,500           -

  Net Loss for the year ended December 31, 1989                  -        -         -     (39,455)
                                                        ----------  -------  ---------  ----------

Balance-December 31, 1989                                9,921,241    9,921   681,241    (710,049)

  Net loss for the year ended December 31, 1990                  -        -         -      (1,803)
                                                        ----------  -------  ---------  ----------

Balance-December 31, 1990                                9,921,241    9,921   681,241    (711,852)

  Net loss for the year ended December 31, 1991                  -        -         -      (1,599)
                                                        ----------  -------  ---------  ----------

Balance-December 31, 1991                                9,921,241    9,921   681,241    (713,451)

  Expenses paid by officers of the Corporation                   -        -     7,179           -

  Net loss for the year ended December 31, 1992                  -        -         -      (2,001)
                                                        ----------  -------  ---------  ----------

Balance-December 31, 1992                                9,921,241    9,921   688,420    (715,452)

  Expenses paid by officers of the Corporation                   -        -    13,132           -

  Net loss for the year ended December 31, 1993                  -        -         -      (5,075)
                                                        ----------  -------  ---------  ----------

Balance - December 31, 1993                              9,921,241    9,921   701,552    (720,527)

Expenses paid by officers of
 the Corporation (Note 4)                                        -        -    17,971           -

Issuance of Common Stock for
 services performed to corporation
 at $.16 per share                                          40,000       40     6,255           -
</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       17
<PAGE>
<TABLE>
<CAPTION>
                                   RENU-U INTERNATIONAL, INC.
                                  ( Development Stage Company)
                          Statements of Stockholders' Equity (Continued)


                                                    Common  Stock      Capital     Retained
                                                 ------------------   In Excess    Earnings
                                                   Shares    Amount     of Par     (Deficit)
                                                 ---------  -------  ----------  ------------
<S>                                              <C>        <C>      <C>         <C>
Net Loss for the year ended
 December 31, 1994                                       -  $     -  $       -   $   (39,877)
                                                 ---------  -------  ----------  ------------

Balance - December 31, 1994                      9,961,241    9,961    725,778      (760,404)

Expenses paid by officers of
 the Corporation (Note 4)                                -        -      9,901             -

Net Loss for the year ended
 December 31, 1995                                       -        -          -       (23,536)
                                                 ---------  -------  ----------  ------------

Balance - December 31, 1995                      9,961,241    9,961    735,679      (783,940)

Expenses paid by officers of
 the corporation (Note 3)                                -        -     10,013             -

Equipment paid for and
 contributed by officers of
 the corporation (Note 3)                                -        -      7,650             -

Net loss for the year ended
 December 31, 1996                                       -        -          -       (50,183)
                                                 ---------  -------  ----------  ------------

Balance - December 31, 1996                      9,961,241    9,961    753,342      (834,123)


Net loss for the year ended
 December 31, 1997                                       -        -          -      (159,953)
                                                 ---------  -------  ----------  ------------

Balance - December 31, 1997                      9,961,241    9,961    753,342      (994,076)

Net loss for the year ended
   December 31, 1998                                       -           -        -    (83,755)

Balance - December 31, 1998                      9,961,241  $ 9,961  $ 753,342   $(1,077,831)
                                                 =========  =======  ==========  ============
</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       18
<PAGE>
<TABLE>
<CAPTION>
                                  RENU-U INTERNATIONAL, INC.
                                (A Development Stage Company)
                                  Statements of Cash Flows
                                                                                          For the
                                                                                          Period
                                                                                        During  the
                                                                                        Development
                                                                                        Stage  from
                                                                                        January  1,
                                                                                        1983 Through
                                                                          December 31,
                                                                -----------------------
                                                              December 31,
                                                                  1998        1997        1998
                                                                ---------  ----------  ----------
<S>                                                             <C>        <C>         <C>
Cash Flow Provided From Operations

   Net loss from operations                                     $(83,755)  $(159,953)  $(526,780)

   Adjustments to reconcile net loss to net cash
     provided by operating activities

       Amortization and Depreciation                               6,526       2,995      10,112
       Issuance of capital stock for services                          -           -      28,795
       Bad debts                                                  16,418           -      31,418
       Changes in inventory - resale                              (9,520)          -      35,040
        Changes in current liabilities                           135,196     116,201     252,828
        Losses of equipement                                      11,135      11,135
        Expenses paid by officer                                       -           -      90,807
                                                                ---------  ----------  ----------
             Net Cash Flow Used For Operations                    76,000     (40,757)    (66,645)
                                                                ---------  ----------  ----------

Cash Flow Provided From Financing Activities

      Net changes in long term debt                              (76,528)     25,000      44,472
      Issuance of capital stock for cash                               -           -     175,000
                                                                ---------  ----------  ----------
              Net Cash Flow Provided From Financing Activities   (76,528)     25,000     219,472
                                                                ---------  ----------  ----------

Cash Flow Used For Investing Activities

      Investment in subsidiary                                         -           -    (105,000)
      Purchase of property and equipment                          (1,120)    (35,777)    (47,780)
                                                                ---------  ----------  ----------
              Net Cash Flow used for investing activities         (1,120)    (35,777)   (152,780)
                                                                ---------  ----------  ----------

Net Cash Flow                                                     (1,648)    (51,534)         47

Cash-Beginning of Period                                           1,695      53,229           -
                                                                ---------  ----------  ----------

Cash-End of Period                                              $     47   $   1,695   $       47
                                                                =========  ==========  ==========

Supplemental Disclosure of Cash Flow Information:

    Cash paid during the period for:
        Interest                                                $   11,669   $   1,023   $16,625
        Income Tax                                                       -       1,200     1,200

     Equipment contributed by officer
  $                                                                    -   $       -   $   7,650
</TABLE>
     See  accompanying  accountant's  report  and  notes to financial statements

                                       19
<PAGE>
                           RENU-U INTERNATIONAL, INC.
                          (A Development Stage Company)
                          Notes to Financial Statements
                                December 31, 1998


1.  ORGANIZATION

The Company was incorporated under the laws of the State of Delaware on June 14,
1971. There have been name changes and authorized stock changes resulting in the
present  name,  the  authorized common shares, and the preferred shares shown in
the  balance  sheet.

The  Company  has  been  involved  in various activities over the years, none of
which  were  successful.  During  the  year  1983,  the Company discontinued all
operations  until  1996 when the Company started developmental work on device to
be used in the physical care field and during June 1999 the Company completed an
acquisition  and  reorganization.  (Note  6  -  subsequent  events)

The  company  is  considered  to  be  in  the  development  stage  after  1982.

2.  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

Accounting  Methods
-------------------

The  Company  recognizes  income  and  expenses  based  on the accrual method of
accounting.

Dividend  Policy
----------------

The  Company  has  not  yet  adopted  a  policy  regarding payment of dividends.

Income  Taxes
-------------

On  December  31,  1998, the Company  had a net operating loss  carry forward of
$1,077,831.  The  tax benefit from the loss carry forward  has been fully offset
by  a  valuation  reserve  because the use of the future tax benefit is doubtful
since  the  Company  cannot  project  a  reliable net profit in the near future.
$563,551  of  the loss carryforward has expired and the balance expires starting
in  the  years  2000  through  2019.

Earnings  (Loss)  Per  Share
----------------------------

Earnings  (loss)  per  share  amounts are computed based on the weighted average
number  of  shares  actually  outstanding.

Cash  and  Cash  Equivalents
----------------------------

The  Company  considers all highly liquid instruments purchased with a maturity,
at  the  time  of  purchase,  of less than three months, to be cash equivalents.

Property  and  Equipment
------------------------

Property  and  equipment  is  recorded  at  cost  on the date of acquisition and
consists  of  the  following  on  December  31,  1998



     Office  &  manufacturing  equipment          $   37,096
     Less:  accumulated  depreciation                 (7,451)
                                                 ------------
                                                  $   29,645
                                                 ============

Depreciation  expense  is  computed on the straight-line method over the  useful
lives of the assets ranging from three to seven years.  Depreciation expense for
the  period  ended  December  31,  1998  was  $6,526  and  $2,995  for  1997.

                                       20
<PAGE>
     See  accompanying  accountant's  report  and  notes to financial statements


                           RENU-U INTERNATIONAL, INC.
                          (A Development Stage Company)
                          Notes to Financial Statements
                                December 31, 1998

2.  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  -  continued

Financial  Instruments
----------------------

The  carrying  amounts  of  financial  instruments,  including  all  assets  and
liabilities  shown  in  the  balance  sheet,  are considered by management to be
their  estimated  fair  values  because of the events outlined in notes 4 and 6.
These  values  are  not  necessarily  indicative of the amounts that the Company
could  realize  in  a  current  market  exchange.

Estimates  and  Assumptions
---------------------------

Management  uses  estimates and assumptions in preparing financial statements in
accordance  with  generally accepted accounting principles.  Those estimates and
assumptions  affect  the  reported  amounts  of the assets  and liabilities, the
disclosure  of  contingent assets and liabilities, and the reported revenues and
expenses.  Actual  results  could  vary  from the estimates that were assumed in
preparing  these  financial  statements.

3.   LONG  TERM  DEBT

Long  term debt consists of lines of credit from banks amounting to $44,472 with
interest  only  payments  for  the  near  future.  Officers  of the Company have
guaranteed  the  loans.


4.   GOING  CONCERN

The  Company's  financial statements have been prepared using generally accepted
accounting  principles  applicable  to  a  going  concern which contemplates the
realization  of  assets  and  liquidation of liabilities in the normal course of
business.  The  Company  has  sustained substantial losses and does not have the
current  assets  to service its current liabilities for the coming year, however
during  June  1999  all  assets and its business in the physical care field were
transferred  in exchanged for the assumption of all liabilites and therefore the
book  value  of  the  liabilities  is  assumed  to  be the fair value. (Note 6 -
Subsequent  Events)

5.   RELATED  PARTY  TRANSACTIONS

Officers  of  the  Company have guaranteed lines of credit with banks.  (Note 3)

6.   SUBSEQUENT  EVENTS

During  June  1999  the  Company  transferred all assets and its business in the
physical  care  field  in exchange for the assumption of all its liabilities, by
related  parties,  as  part  of  an  acquisition  and reorganization between the
Company and RGB Technology Group, Inc. and  Kimrose Holdings, a related party to
RGB  Technology  Inc.,  which  included the issuance of 90,000,000 shares of the
Company  and  then  a  reverse  stock split of the Company stock at 30 shares of
outstanding  stock  for  one  share.

                                       21
<PAGE>
                       CONSENT OF INDEPENDENT ACCOUNTANTS

We  hereby  consent to the use of our audit report of Renu U International, Inc.
dated  August  5, 1999 for the year ended December 31, 1998 in their Form 10K-SB
Annual  Report


ANDSERSEN  ANDERSEN  &  STRONG

Salt  Lake  City,  Utah
August  5,  1999

                                       22
<PAGE>

                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

WE  HEREBY CONSENT TO THE USE OF OUR REPORT, DATED JULY 16, 1998, IN THIS ANNUAL
REPORT  ON  FORM  10-KSB  FOR  THE  YEAR  ENDED  DECEMBER  31,  1997  FOR RENU-U
INTERNATIONAL,  INC.

CROUCH,  BIERWOLF  &  CHISOLM

SALT  LAKE  CITY,  UTAH
AUGUST  23,  1999

                                       23
<PAGE>